Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDialight Regulatory News (DIA)

Share Price Information for Dialight (DIA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 160.50
Bid: 152.00
Ask: 169.00
Change: 0.00 (0.00%)
Spread: 17.00 (11.184%)
Open: 160.50
High: 0.00
Low: 0.00
Prev. Close: 160.50
DIA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

REX Retail Offer

26 Sep 2023 17:07

RNS Number : 7333N
Dialight PLC
26 September 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, SOUTH AFRICA OR JAPAN, OR ANY MEMBER STATE OF THE EEA, OR ANY OTHER JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT

 

THE COMMUNICATION OF THIS ANNOUNCEMENT AND ANY OTHER DOCUMENTS OR MATERIALS RELATING TO THE REX RETAIL OFFER AS A FINANCIAL PROMOTION IS ONLY BEING MADE TO, AND MAY ONLY BE ACTED UPON BY, THOSE PERSONS IN THE UNITED KINGDOM FALLING WITHIN ARTICLE 43 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (WHICH INCLUDES AN EXISTING MEMBER OF DIALIGHT PLC). ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT RELATES IS AVAILABLE ONLY TO SUCH PERSONS AND WILL BE ENGAGED IN ONLY WITH SUCH PERSONS. THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY, AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF DIALIGHT PLC

 

 

26 September 2023

 

Dialight plc

 

("Dialight" or the "Company")

 

REX Retail Offer

 

Dialight plc is pleased to announce an offer to its existing retail investors (the "REX Retail Offer") of up to £1,000,000 of new ordinary shares of 1.89 pence each ("Ordinary Shares") in the capital of the Company (the "REX Retail Offer Shares").

 

In addition to the REX Retail Offer, the Company is also conducting a placing (the "Placing") of Ordinary Shares (the "Placing Shares and together with the REX Retail Offer Shares, the "New Ordinary Shares") to institutional investors by way of a bookbuild process (the "Bookbuilding Process"). The price of the New Ordinary Shares is £1.59 per share.

 

A separate announcement has been made regarding the Placing and its terms. For the avoidance of doubt, the REX Retail Offer is not part of the Placing.

 

Certain of the Company's shareholders holding 10% or more of the issued ordinary share capital have indicated their intention to participate in the Placing. Depending on the results of the Placing and the REX Retail Offer, the participation of such shareholders may constitute a related party transaction pursuant to Listing Rule 11 requiring shareholder approval in accordance with Listing Rule 11.1.7R. Accordingly, the Company may be required to publish a notice of general meeting to convene a shareholders' meeting and seek the requisite shareholder approval. The Company can call a general meeting on 21 clear days' notice. If required, the Company will make further announcements in due course regarding such general meeting.

 

The REX Retail Offer and the Placing are conditional on the New Ordinary Shares being admitted to the Official List of the Financial Conduct Authority (the "FCA") and to trading on the Main Market of the London Stock Exchange plc ("Admission"). Depending on the results of the Placing and the REX Retail Offer, settlement of the New Ordinary Shares and Admission may be conditional on obtaining shareholder approval, in which case the Company would publish a notice of general meeting to convene a shareholders' meeting to seek the requisite shareholder approval in accordance with Listing Rule 11.1.7R as described above. Accordingly, settlement of the New Ordinary Shares and Admission may take place following shareholder approval being obtained at the relevant shareholders' meeting. If shareholder approval is not required, it is expected that Admission will become effective not later than 8.00 a.m. (London time) on or around 29 September 2023 (or such later time and/or date as may be agreed between the Company and Peel Hunt) and that dealings in the Placing Shares will commence at that time. Completion of the REX Retail Offer is conditional, inter alia, upon the completion of the Placing.

 

REX Retail Offer

 

The Company values its retail shareholder base and believes that it is appropriate to provide its existing retail shareholders in the United Kingdom the opportunity to participate in the REX Retail Offer via participating financial intermediaries.

 

Therefore, the Company is making the REX Retail Offer open to eligible investors in the United Kingdom following release of this announcement. 

 

The REX Retail Offer is expected to close at 6:30pm on 26 September 2023. Eligible shareholders should note that financial intermediaries may have earlier closing times.

 

At the time of this announcement the following intermediaries have confirmed their participation in the REX Retail Offer:

 

· AJ Bell

· Hargreaves Lansdown

· interactive investor

 

Other retail brokers or wealth managers wishing to participate in the REX Retail Offer on behalf of existing retail shareholders, should contact info@rexretail.com.

 

To be eligible to participate in the REX Retail Offer, applicants must be a customer of a participating intermediary and, as at the date hereof, must be a shareholder in the Company.

 

Eligible investors wishing to subscribe for REX Retail Offer Shares should contact their broker or wealth manager who will confirm if they are participating in the REX Retail Offer.

 

There is a minimum subscription of £50 per investor. The terms and conditions on which investors subscribe will be provided by the relevant financial intermediaries including relevant commission or fee charges.

 

The Company reserves the right to scale back any order under the REX Retail Offer at its discretion. The Company reserves the right to reject any application for subscription under the REX Retail Offer without giving any reason for such rejection.

 

It is vital to note that once an application for REX Retail Offer Shares has been made and accepted via an intermediary, it cannot be withdrawn.

 

The New Ordinary Shares will, when issued, be credited as fully paid and will rank pari passu in all respects with existing Ordinary Shares including the right to receive all dividends and other distributions declared, made or paid after their date of issue.

 

It is a term of the REX Retail Offer that the total value of the REX Retail Offer Shares available for subscription at the Issue Price does not exceed £1,000,000.

 

The REX Retail Offer is offered in the United Kingdom under the exemption from the requirement to publish a prospectus in section 86(1)(e) of FSMA. As such, there is no need for publication of a prospectus pursuant to the Prospectus Regulation Rules of the Financial Conduct Authority, or for approval of the same by the Financial Conduct Authority. The REX Retail Offer is not being made into any jurisdiction other than the United Kingdom.

 

No offering document, prospectus or admission document has been or will be prepared or submitted to be approved by the Financial Conduct Authority (or any other authority) in relation to the REX Retail Offer, and investors' commitments will be made solely on the basis of the information contained in this announcement and information that has been published by or on behalf of the Company prior to the date of this announcement by notification to a Regulatory Information Service in accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, the Market Abuse Regulation (EU Regulation No. 596/2014) ("MAR") and MAR as it forms part of United Kingdom law by virtue of the European Union (Withdrawal) Act 2018 (as amended).

Investors should make their own investigations into the merits of an investment in the Company. Nothing in this announcement amounts to a recommendation to invest in the Company or amounts to investment, taxation or legal advice.

 

It should be noted that a subscription for REX Retail Offer Shares and investment in the Company carries a number of risks. Investors should take independent advice from a person experienced in advising on investment in securities such as the REX Retail Offer Shares if they are in any doubt.

 

An investment in the Company will place capital at risk. The value of investments, and any income, can go down as well as up, so investors could get back less than the amount invested.

 

Neither past performance nor any forecasts should be considered a reliable indicator of future results.

 

For Further Information

 

Dialight plc

Neil Johnson, Non-Executive Chairman

Fariyal Khanbabi, Group Chief Executive

 

REX Retail

Info@rexretail.com

 

T: +44 (0) 203 058 3542

 

 

Further information on the Company can be found on its website at https://www.dialight.com/

 

The Company's LEI is GB0033057794

 

This announcement should be read in its entirety. In particular, the information in the "Important Notices" section of the announcement should be read and understood.

 

Important Notices

 

The content of this announcement, which has been prepared by and is the sole responsibility of the Company.

 

This announcement and the information contained herein is not for release, publication or distribution, directly or indirectly, in whole or in part, in or into or from the United States (including its territories and possessions, any state of the United States and the District of Columbia (the "United States" or "US")), Australia, Canada, New Zealand, Japan, the Republic of South Africa, any member state of the EEA or any other jurisdiction where to do so might constitute a violation of the relevant laws or regulations of such jurisdiction.

 

The REX Retail Offer Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act") or under the applicable state securities laws of the United States and may not be offered or sold directly or indirectly in or into the United States. No public oering of the REX Retail Offer Shares is being made in the United States. The REX Retail Offer Shares are being oered and sold outside the United States in "oshore transactions", as dened in, and in compliance with, Regulation S under the US Securities Act. In addition, the Company has not been, and will not be, registered under the US Investment Company Act of 1940, as amended.

 

This announcement does not constitute an offer to sell or issue or a solicitation of an offer to buy or subscribe for REX Retail Offer Shares in the United States, Australia, Canada, New Zealand, Japan, the Republic of South Africa, any member state of the EEA or any other jurisdiction in which such offer or solicitation is or may be unlawful. No public offer of the securities referred to herein is being made in any such jurisdiction.

 

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the US Securities Act, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.

 

The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

REX is a proprietary technology platform owned and operated by Peel Hunt LLP (registered address at 7th Floor, 100 Liverpool Street, London EC2M 2AT; FRN 530083). Peel Hunt LLP ("Peel Hunt") is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for the Company and for no-one else and will not regard any other person (whether or not a recipient of this announcement) as its client in relation to the REX Retail Offer and will not be responsible to anyone other than the Company for providing the protections afforded to its clients, nor for providing advice in connection with the REX Retail Offer, Admission and the other arrangements referred to in this announcement.

 

The value of Ordinary Shares and the income from them is not guaranteed and can fall as well as rise due to stock market movements. When you sell your investment, you may get back less than you originally invested. Figures refer to past performance and past performance is not a reliable indicator of future results. Returns may increase or decrease as a result of currency fluctuations.

 

Certain statements in this announcement are forward-looking statements which are based on the Company's expectations, intentions and projections regarding its future performance, anticipated events or trends and other matters that are not historical facts. These forward-looking statements, which may use words such as "aim", "anticipate", "believe", "intend", "estimate", "expect" and words of similar meaning, include all matters that are not historical facts. These forward-looking statements involve risks, assumptions and uncertainties that could cause the actual results of operations, financial condition, liquidity and dividend policy and the development of the industries in which the Company's businesses operate to differ materially from the impression created by the forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Given those risks and uncertainties, prospective investors are cautioned not to place undue reliance on forward-looking statements.

 

These forward-looking statements speak only as at the date of this announcement and cannot be relied upon as a guide to future performance. The Company and Peel Hunt expressly disclaim any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the assumptions, conditions or circumstances on which any such statements are based unless required to do so by the Financial Conduct Authority, the London Stock Exchange or applicable law.

 

The information in this announcement is for background purposes only and does not purport to be full or complete. None of Peel Hunt or any of its affiliates, accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to this announcement, including the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of the announcement or its contents or otherwise arising in connection therewith. Peel Hunt and its affiliates, accordingly disclaim all and any liability whether arising in tort, contract or otherwise which they might otherwise be found to have in respect of this announcement or its contents or otherwise arising in connection therewith.

 

Any indication in this announcement of the price at which the Ordinary Share have been bought or sold in the past cannot be relied upon as a guide to future performance. Persons needing advice should consult an independent financial adviser. No statement in this announcement is intended to be a profit forecast and no statement in this announcement should be interpreted to mean that earnings or target dividend per share of the Company for the current or future financial years would necessarily match or exceed the historical published earnings or dividends per share of the Company.

 

Neither the content of the Company's website (or any other website) nor the content of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement. The REX Retail Offer Shares to be issued or sold pursuant to the REX Retail Offer will not be admitted to trading on any stock exchange other than the London Stock Exchange.

 

It is further noted that the REX Retail Offer is only open to investors in the United Kingdom who fall within Article 43 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (which includes an existing member of the Company).

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEPPUQUBUPWGQQ
Date   Source Headline
19th Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 202411:00 amRNSAdmission of New Shares
12th Mar 20245:55 pmRNSHolding(s) in Company
12th Mar 20244:56 pmRNSHolding(s) in Company
26th Feb 20242:39 pmRNSDirector/PDMR Shareholding
19th Feb 20249:16 amRNSDirectorate Change
19th Feb 20247:00 amRNSStatement re second interim results
16th Feb 20247:00 amRNSDirectorate Change
30th Jan 20247:00 amRNSCFO Appointment
30th Jan 20247:00 amRNSTrading Update
2nd Jan 20247:00 amRNSSanmina Litigation
29th Nov 20231:04 pmRNSSanmina Litigation
7th Nov 20235:40 pmRNSHolding(s) in Company
7th Nov 20235:24 pmRNSHolding(s) in Company
7th Nov 20233:52 pmRNSHolding(s) in Company
1st Nov 202312:03 pmRNSPDMR Shareholding
1st Nov 202311:50 amRNSTotal Voting Rights and Capital
1st Nov 202311:15 amRNSBlock listing Interim Review
31st Oct 20234:32 pmRNSHolding(s) in Company
27th Oct 202312:05 pmRNSResults of General Meeting
4th Oct 202311:52 amRNSCirc re. Related Party Transaction
27th Sep 20237:00 amRNSResult of Equity Issue
26th Sep 20235:07 pmRNSREX Retail Offer
26th Sep 20235:05 pmRNSProposed Placing and Retail Offer
18th Sep 202312:25 pmRNSStatement re Update on Financing
18th Sep 20237:00 amRNSDirector Change
18th Sep 20237:00 amRNSUnaudited Half Year Results 2023
26th Jun 20237:00 amRNSDirectorate Change and Notice of Results
8th Jun 20237:00 amRNSDirector/PDMR Shareholding
7th Jun 20237:00 amRNSDirectorate Changes
16th May 20235:47 pmRNSResult of AGM
16th May 20237:00 amRNSAGM Trading Update
27th Apr 20237:00 amRNSDirector/PDMR Shareholding
17th Apr 20237:00 amRNSDirector/PDMR Shareholding
14th Apr 20231:03 pmRNSDirector/PDMR Shareholding
12th Apr 202312:30 pmRNSNotice of AGM
6th Apr 20232:35 pmRNSTotal Voting Rights
6th Apr 20232:20 pmRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSDirectorate Change
3rd Apr 20231:03 pmRNSBlock listing Interim Review
3rd Apr 20237:00 amRNSAnnual Financial Report
30th Mar 20237:00 amRNSDirectorate Change
27th Mar 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSDirectorate Change
15th Mar 20235:14 pmRNSDirector Declaration
15th Mar 20237:00 amRNSSanmina Litigation
13th Jan 20237:00 amRNSDirectorate Change
13th Jan 20237:00 amRNSTrading Statement
5th Jan 20234:40 pmRNSSecond Price Monitoring Extn
5th Jan 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.